Altered gene expression for tumor necrosis factor-α and its receptors during drug and dietary modulation of insulin resistance

Endocrinology

Volumn 134, Issue 1, 1994, Pages 264-270

  Hofmann, Cecilia ^a,b,d   Lorenz, Kathryn ^a,b,d   Braithwaite, Susan S ^a,b,d   Colca, Jerry R ^c,d   Palazuk, Barbara J ^c,d   Hotamisligil, Gökhan S ^d,e   Spiegelman, Bruce M ^d,e  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; GLUCOSE; HEXOKINASE; PIOGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORTHERN BLOTTING; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 0027972524     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.134.1.8275942     Document Type: Article

References (55)

1. Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B 1992 The tissue distribution of tumor necrosis factor synthesis during endotoxemia. J Clin Invest 90:693-698
2. Tracey KJ, Cerami A 1992 Tumor necrosis factor and regulation of metabolism in infection: role of systemic versus tissue levels. Proc Soc Exp Biol Med 200:233-239
3. Vilcek J, Lee TH 1991 Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions. J Biol Chem 266: 7313-7316
4. Fiers W 1991 Tumor necrosis factor. Characterization at the molecular, cellular, and in vivo level. FEBS Lett 285:199-212
5. Old LJ 1988 Tumor necrosis factor. Sci Am 258:59-75
6. Rosenblum MG, Donato NJ 1988 Tumor necrosis factor-alpha: a multifaceted peptide hormone. Crit Rev Immunol 9:21-40
7. Carswell EA, Old LJ, Kassel S, Green S, Fiore N, Williamson B 1975 An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670
8. Tracey KJ 1991 Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ Shock 35:123-128
9. Spooner CE, Markowitz NP, Saravolatz LD 1992 The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol 62:S11-SS17
10. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert JD, Shires GT, Cerami A 1986 Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474
11. Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A, Socher SH 1987 Tumors secreting human TNF/ cachectin induce cachexia in mice. Cell 50:555-563
12. Tracey KJ, Wei H, Manogue KR, Fong Y, Hesse DG, Hguyen HT, Kuo GC, Beutler B, Cotran RS, Cerami A, Lowry SF 1988 Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 167:1211-1227
13. Lahdevirta J, Maury CPJ, Teppo A-M, Repo H 1988 Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 85:289-291
14. Cheng J, Turksen K, Yu QH, Schreiber H, Teng M, Fuchs E 1992 Cachexia and graft-vs-host disease-type skin changes in keratin promoter-driven TNFalpha fransgenic mice. Genes Dev 6: 1444-1456
15. Tartaglia LA, Goeddel DV 1992 Two TNF receptors. Immunol Today 13:151-153
16. Loetscher H, Pan YE, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W 1991 Molecular cloning and expression of the human 55kD rumor necrosis factor receptor. Cell 61:351-360
17. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GHW, Gatanaga G, Granger GA, Lentz R, Raab H, Kohr WJ, Goeddel DV 1991 Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361-370
18. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, Dower SK, Cosman D, Goodwin RG 1990 A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019-1023
19. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GHW, Chen EY, Goeddel DV 1991 Cloning and expression of cDNAs for two distinct murine tumor necrosis factors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88:2830-2834
20. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV 1991 The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 88:9292-9296
21. Hotamisligil GS, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91
22. Lang CH, Dobrescu C, Bagby GJ 1992 Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130:43-52
23. McCall JL, Tuckey JA, Parry BR 1992 Serum tumor necrosis factor alpha and insulin resistance in gastrointestinal cancer. Br J Surg 79:1361-1363
24. Van der Poll T, Romijnm A, Endert E, Borm JJJ, Buller HR, Sauerwein HP 1991 Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 261:E457-E465
25. Iwatsuka H, Shino A, Suzuoki Z 1970 General survey of diabetic features of yellow KK mice. Endocrinol Jpn 17:23-25
26. Hofmann CA, Colca JR 1992 New oral thiazolidinedione antidiabetic agents act as insulin-sensitizers. Diabetes Care 15:1075-1078
27. Chang AY, Wyse BM, Copeland EJ, Peterson T, Ledbetter SR 1986 The Upjohn colony of KKAY mice: a model for obese type II diabetes. In: Serrano-Rios M, Lefebvre PJ (eds) Diabetes 1985. Elsevier, Amsterdam, pp 466-470
28. Zaharto DS, Beck LV 1968 Studies of a simplified plasma insulin immunoassay using cellulose powder. Diabetes 17:444-457
29. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
30. Fourney RM, Miyashi J, Day RS, Paterson MC 1988 Northern blotting: efficient RNA staining and transfer. FOCUS 10:5-7
31. Spiegelman BM, Frank M, Green H 1983 Molecular cloning of mRNA from 3T3 adipocytes. J Biol Chem 258:10083-10089
32. Birnbaum MJ 1989 Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell 57:305-315
33. Pennica D, Hayflick JS, Bringman TS, Palladino MA, Goeddel DV 1985 Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc Natl Acad Sci USA 82: 6060-6064
34. Bonini J, Hofmann C 1991 A rapid, accurate, nonradioactive method for quantitating RNA on agarose gels. Biotechniques 11:708-709
35. Klip A, Marette A 1992 Acute and chronic signals controlling glucose transport in skeletal muscle. J Cell Biochem 48:51-60
36. Yki-Jarvinen H, Sahlin K, Ren JM, Koivisto VA 1990 Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes 39:157-167
37. DeFronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren J 1985 Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-edpendent (type II) diabetes mellitus. J Clin Invest 76:149-155
38. Hofmann C, Lorenz K, Colca JR 1991 Glucose transport deficiency in diabetic animals is corrected by treatment with the oral anti-hyperglycemic agent pioglitazone. Endocrinology 129:1915-1925
39. Friedman JM, Leibel RL 1992 Tackling a weighty problem. Cell 69:217-220
40. Moller DE, Flier JS 1991 Insulin resistance-mechanisms, syndromes, and implications. N Engl J Med 325:938-948
41. 1993 Consensus statement: detection and management of lipid disorders in diabetes. Diabetes Care 16:106-112
42. Spiegelman BM, Hotamisligil GS 1993 Through thick and thin: wasting, obesity, and TNFalpha. Cell 73:625-627
43. Cornelius P, Marlowe M, Lee MD, Pekala PH 1990 The growth factor-like effects of tumor necrosis factor-alpha. Stimulation of glucose transport activity and induction of glucose transporter and immediate early gene expression in 3T3-L1 preadipocytes. J Biol Chem 265:20506-20516
44. Stephens JM, Carter BZ, Pekala PH, Malter JS 1992 Tumor necrosis factor-alpha induced glucose transporter (GLUT1) mRNA stabilization in 3T3-L1 preadipocytes. J Biol Chem 267:8336-8341
45. Pessin JE, Bell GI 1992 Mammalian facultative glucose transporter family:structure and molecular regulation. Annu Rev Physiol 54:911-930
46. Stephens JM, Pekala PH 1992 Transcriptional repression of the C/ EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor. J Biol Chem 267:13580-13584
47. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H 1993 Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J Immunol 150:4346-4353
48. Ikeda H, Taketomi S, Sugiyama Y, Sodha T, Meguro K, Fujita T 1990 Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneim Forsch Drug Res 40:156-160
49. Sugiyama Y, Taketomi S, Shimura Y, Ikeda H, Fujita T 1990 Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats. Arzneim Forsch Drug Res 40:263-268
50. Sugiyama Y, Shimura Y, Ikeda H 1990 Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats. Arzneim Forsch Drug Res 40:436-440
51. Hofmann CA, Edwards III CW, Hillman RM, Colca JR 1992 Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone: evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression. Endocrinology 130:735-740
52. Harris PKW, Kletzien RF 1993 Identification of a pioglitazone response element in the aFABP gene. Diabetes 42:144A
53. Dailey C, Palazuk BJ, Jacob C, Bleasdale J, Colca J 1993 Pioglitazone augments early steps in the insulin transduction system. Diabetes 42:116A
54. Kobayashi M, Iwanishi M, Egawa K, Shigeta Y 1992 Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes 41:476-483
55. Han J, Brown T, Beutler B 1990 Endotoxin-responsive sequences control cachectin/TNF biosynthesis at the translational level. J Exp Med 171:465-475